Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve the safety, effectiveness and costs of patient care. While not all Hospira products are available in all countries, Hospira's portfolio of products and services includes four major product lines:
These products are used by hospitals, alternate site clinics, home healthcare providers and long-term care facilities.
Learn about the Hospira products available in United Kingdom. For more information about Hospira's global business, visit Hospira's corporate Web site.
As a leading manufacturer of specialty injectable pharmaceuticals within the United States, Hospira offers approximately 130 generic injectable drugs in over 600 dosages and formulations. Product areas include cardiovascular, anaesthesia, anti-infectives, analgesics, emergency and other therapeutic segments. At the end of 2005, the company had 46 products in development, up from 36 products in development in 2004. Specialty injectables will continue to be a large growth opportunity for Hospira as more than $5 billion worth of proprietary, non-biologic drugs will face patent expiration in the United States by 2010.
Two components comprise Hospira’s strong positions in different, but integrated, markets – Infusion Therapy and Medication Management Systems. Infusion Therapy includes large intravenous solutions, nutritionals and administration sets – essential in virtually every aspect of hospital patient care. Medication Management Systems includes infusion pumps and related disposable sets and software, playing a critical role in improving patient safety. Hospira’s installed global base includes more than 400,000 pumps. Hospira MedNet® is a drug-dose safety software that helps reduce medication errors. In 2005, wireless, networking and cross-platform capabilities were added to increase hospital utility, cost-effectiveness and interoperability with hospital information technology.
One 2 One® is Hospira’s contract manufacturing business that utilizes our drug delivery, formulation, filling and finishing expertise to produce injectable products on behalf of other companies. One 2 One’s customers include some of the world’s largest proprietary pharmaceutical and biotechnology companies.
Hospira has a significant presence in critical care areas of the hospital including the operating room and intensive-care units. Hospira devices include invasive blood-pressure monitoring and closed blood-sampling kits, cardiac catheters and angiography kits, and a brain-function monitoring system used as an adjunct to traditional methods to assess sedation levels. Other also includes sales of Hospira products to alternate site clinics, home healthcare providers and long-term care facilities.